TRILC.E — Turk Ilac ve Serum Sanayi AS Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual income statement for Turk Ilac ve Serum Sanayi AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	200	673	1,637	2,774	2,568
Cost of Revenue
Gross Profit	99.1	120	354	631	802
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	134	597	1,463	2,393	2,030
Operating Profit	66	75.8	174	382	538
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	40.3	46.9	-9.67	119	98.4
Provision for Income Taxes
Net Income After Taxes	33.3	37.1	-81.7	153	72.4
Net Income Before Extraordinary Items
Net Income	33.3	37.1	-81.7	153	72.4
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	33.3	37.1	-81.7	153	72.4
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.234	0.227	-0.504	0.943	0.461
Dividends per Share